You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Csrnewsdaily.com Issues Investment Alert On (NYSE: SCHW), (NYSE: CVX), (NYSE: DGX), (AMEX: DNN), (NYSE: GS)

Print Share

Pompano Beach, FL, Jan 16, 2013 (eTeligis.com via COMTEX) Charles Schwab Corp (NYSE:SCHW) decreased 0.85% to $15.16 on a traded volume of 111k shares. The Company announced fourth quarter results. Earnings were $189 million or 15 cents per share compared to $163 million or 13 cents in the previous year period. Net revenue was $1.22 billion compared to $1.11 billion in the prior year period. However, analysts expected earnings of 15 cents per share on $1.21 billion of revenue.

Will SCHW Move Higher After Today's Sudden Selling Activities? Don't Miss The Free Trend Analysis here http://csrnewsdaily.com/c1/?company=SCHW

Chevron Corporation (NYSE:CVX) slipped 0.15% to $113.27 on a traded volume of 121k shares. The Company's China subsidiary has entered into production sharing contracts with China National Offshore Oil Corporation for two exploration blocks in the South China Sea's Pearl River Mouth Basin. Under the terms of the agreement, Chevron China Energy Company will hold a 100% interest in blocks 15/10 and 15/28 in the Pearl River Mouth Basin.

How Should Investors Trade CVX After The Recent Momentum, Find Out Here http://csrnewsdaily.com/c1/?company=CVX

Quest Diagnostics Inc (NYSE:DGX) declined 0.28% to $59.67. The Company intends to sell its HemoCue diagnostic products business. This is a part of the Company's strategy to refocus on diagnostic information services. HemoCue develops, produces and markets point-of-care testing systems.

Get Free Special Trend Analysis On DGX Here http://csrnewsdaily.com/c1/?company=DGX

Denison Mines Corp (USA) (NYSEAMEX:DNN) augmented 1.37% to $1.48 on a traded volume of 54k shares. The Company announced the signing of a Binding Letter of Intent pursuant to which Denison will acquire a portfolio of uranium exploration projects from Fission Energy Corp. Under the terms of the LOI, Denison has agreed to offer shareholders of Fission 0.355 shares of Denison for each share of Fission held on certain conditions. The deal value is approximately $70 million based on the closing price of Denison as of January 15, 2013.

Get Free Special Trend Analysis On DNN Here http://csrnewsdaily.com/c1/?company=DNN

Goldman Sachs Group Inc (NYSE:GS) jumped up 2.58% to $139.12 on a traded volume of 1.0 million shares. The Company announced fourth quarter results. The net income was $2.89 billion versus $1.01 billion in the previous year period. Earnings for common shareholders was $2.83 billion or $5.60 per share compared to $978 million or $1.84 in the prior year period. However, analysts expected earnings of $3.66 per share.

Wells Fargo restated market perform rating on Goldman Sachs in a research note issued to investors.

Get Free Special Trend Analysis On GS Here http://csrnewsdaily.com/c1/?company=GS

About Csrnewsdaily.com

Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer:

The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

CONTACT:

Pacific Dynasty Consultants Inc.

2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062323-287-5171

info@pdcincorp.com

www.csrnewsdaily.com

SOURCE CSRNewsDaily.com

Associated Documentation:Link to submission on http://www.eteligis.comCSRNewsDaily.com_01-16-2013_KMG_1.docx

Copyright eTeligis Inc. 2013. All rights reserved.

**********************************************************************

As of Saturday, 01-12-2013 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated an UPTREND on
06-07-2012 for CVX @ $101.09.

As of Saturday, 01-12-2013 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated a DOWNTREND on
05-07-2012 for DGX @ $57.16.

As of Saturday, 01-12-2013 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated a DOWNTREND on
05-16-2012 for DNN @ $1.38.

For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2013 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.